PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Julia:ReplicateBE – release 0.2.0

Опубликовано 26 октября, 201926 октября, 2019 frozencat

doiGitHub

Вот и подоспел релиз 0.2.0 для оценки параметров смешанной модели репликативного дизайна биоэквивалентности по методу С (EMA) – FDA model.

 

Рубрики: IT, Julia, Mixed Model, Биоэквивалентность

Навигация по записям

Предыдущая запись: ClinicalTrialUtilities: обзор
Следующая запись: Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4

Свежие записи

  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
  • Julia:ReplicateBE – release 0.2.0

Галерея

20170730 144552
20170730 121730
20180816 204834
20180816 145656
IMG-20170805-WA0005
20170730 123751
  • Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-09 By FDA
  • Compounding Quality Center of Excellence | Engage with the Compounding Quality Center of Excellence
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-08 By FDA
  • Compounding Quality Center of Excellence | Instructor-Led Trainings
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-08 By FDA
  • Sexual Enhancement and Energy Product Notifications
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-08 By FDA
  • Black Horse Miracle Honey for Men may be harmful due to hidden drug ingredients
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-08 By FDA
  • Secret Miracle Honey Extra Strength may be harmful due to hidden drug ingredients
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-08 By FDA
  • Black Panther Miracle Honey for Men may be harmful due to hidden drug ingredients
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-08 By FDA
  • Versace Real Honey for Men may be harmful due to hidden drug ingredients
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-08 By FDA
  • FDA Grand Rounds – Forensic Proteomics Applied to FDA-Regulated Products - 07/31/2025
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-07-08 By FDA
  • Human medicines European public assessment report (EPAR): Qdenga, dengue tetravalent vaccine (live, attenuated), Date of authorisation: 05/12/2022, Revision: 4, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-08
  • Public Meeting on the Reauthorization of the Prescription Drug User Fee Act (PDUFA) - 07/14/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-08 By FDA
  • Data Standards Program Strategic Plan and Board
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-08 By FDA
  • CDER Data Standards Program
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-08 By FDA
  • Human medicines European public assessment report (EPAR): Gohibic, vilobelimab, Date of authorisation: 13/01/2025, Revision: 1, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-08
  • Human medicines European public assessment report (EPAR): Ritonavir Viatris (previously Ritonavir Mylan), ritonavir, Date of authorisation: 09/11/2017, Revision: 18, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-08
Предыдущие записи
Тема: Scaffold от Danny Cooper.